Abstract
Laryngeal transplantation has the potential to restore voice, breathing, and swallowing in patients with severe laryngeal dysfunction. Following the first successful human laryngeal transplant in 1998, significant research has been performed and advancements have been made in an effort to expand the applicability of laryngeal transplantation to a larger cohort of patients. The main areas of focus have included efforts to reduce or bypass the need for immunosuppression and to establish volitional control of the laryngeal musculature through reinnervation or pacing techniques. This chapter details the world's first human total laryngeal transplantation and describes the lessons learned until its explantation almost 15 years later. We also summarize many of the major studies and findings that have furthered the science and have contributed to the goal of one day transplanting a fully functional larynx in any patient in need.
Original language | English (US) |
---|---|
Title of host publication | Neurolaryngology |
Publisher | Springer International Publishing |
Pages | 201-213 |
Number of pages | 13 |
ISBN (Electronic) | 9783319617244 |
ISBN (Print) | 9783319617220 |
DOIs | |
State | Published - Oct 30 2017 |
Keywords
- Dendritic cells
- Everolimus
- Immunomodulation
- Immunosuppression
- Laryngeal transplantation
- Larynx
- Regeneration
- Reinnervation
- Tissue-engineering
- Transplantation
ASJC Scopus subject areas
- Medicine(all)